Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Income: 2010-2025

Historic Net Income for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $4.6 million.

  • Niagen Bioscience's Net Income rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 1275.69%. This contributed to the annual value of $8.6 million for FY2024, which is 273.15% up from last year.
  • Per Niagen Bioscience's latest filing, its Net Income stood at $4.6 million for Q3 2025, which was up 26.85% from $3.6 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Net Income peaked at $7.2 million during Q4 2024, and registered a low of -$8.9 million during Q3 2021.
  • In the last 3 years, Niagen Bioscience's Net Income had a median value of $114,000 in 2023 and averaged $1.5 million.
  • As far as peak fluctuations go, Niagen Bioscience's Net Income plummeted by 110.11% in 2021, and later surged by 24,160.00% in 2025.
  • Over the past 5 years, Niagen Bioscience's Net Income (Quarterly) stood at -$5.3 million in 2021, then spiked by 72.88% to -$1.4 million in 2022, then skyrocketed by 107.89% to $114,000 in 2023, then soared by 6,197.37% to $7.2 million in 2024, then skyrocketed by 143.77% to $4.6 million in 2025.
  • Its Net Income was $4.6 million in Q3 2025, compared to $3.6 million in Q2 2025 and $5.1 million in Q1 2025.